Diabetes technology

Effect of Semaglutide on Insulin Dose Reduction in Adults With Type 1 Diabetes and Obesity Using Automated Insulin Delivery Systems: ADJUST-T1D Post Hoc Analysis

Diabetes CarePublished Post hoc analysis of the ADJUST-T1D randomised trial

Authors' conclusion

Semaglutide produced rapid, sustained, and primarily bolus-driven insulin dose reductions, with early effects being largely independent of weight loss in adults with T1D and obesity.

Study context

Population
Adults with T1D and obesity using AID systems
Comparison
Semaglutide 1 mg/week vs placebo
Primary endpoint
Relationship between insulin dose reduction and weight loss; change in total daily insulin dose (TDD)
Follow-up
26 weeks
Methodological detailsdouble-blind, multicentre, placebo-controlled, linear mixed models, mediation analysis
  • Double-blind
  • Multicentre
  • Placebo-controlled
  • Linear mixed models
  • Mediation analysis

Primary result

As reported in the abstract

Reduction in TDD · baseline to week 26

Reduction in TDD

22.6%

95% CI −28.3 to −17.0

Further findings

Bolus and basal insulin reduction · baseline to week 26

Bolus insulin
−30.5% (95% CI −39.5 to −21.5)
Basal insulin
−15.6% (95% CI −21.5 to −9.7)

Basal-to-TDD ratio and insulin dose (units/kg/day), Semaglutide · baseline to week 26

Basal-to-TDD ratio increased
0.56 to 0.62 (P < 0.001)
Insulin dose (units/kg/day) decreased
0.72 to 0.60 (P < 0.001)

Mediation of TDD reduction: direct drug effect vs weight loss · week 4 and week 26

Week 4, direct drug effect
83% (−11.1 units/day)
Week 4, weight loss
17% (−2.3 units/day)
Week 26, direct effect
−11.4 units/day; 52%
Week 26, weight loss
−10.5 units/day; 48%

Daily carbohydrate intake · baseline to 26 weeks

g

Baseline
137 (95% CI 107-167)
26 weeks
107 (95% CI 76-137)

Original publication

Effect of Semaglutide on Insulin Dose Reduction in Adults With Type 1 Diabetes and Obesity Using Automated Insulin Delivery Systems: ADJUST-T1D Post Hoc Analysis. Diabetes Care. Published 22 December 2025. doi:10.2337/dc25-2249

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.